Rhenman & Partners Asset Management Ab Annexon, Inc. Call Options Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding ANNX
# of Institutions
152Shares Held
99.9MCall Options Held
37.6KPut Options Held
119K-
Satter Management Co., L.P.7.41MShares$13 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$12.3 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$11.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$11 Million1.28% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$9.85 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $83.3M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...